Abiraterone Acetate medication is used in the treatment of prostate cancer.
Arechar announces the launch of Abiraterone Acetate under the brand name Abiracine medication is used to treat prostate cancer. It belongs to a class of drugs known as anti-androgens and it works by blocking the production of testosterone and stopping the growth of prostate cancer. It is useful for the prevention of testosterone flare at the initiation of GnRH (gonadotropin-releasing hormone) agonist therapy in men with prostate cancer. The manufacturing unit of Arechar Healthcare has provided key features of Abiracine.
Abiraterone acetate is an innovative drug that offers clinical benefit to patients with hormone-refractory prostate cancer. The administration of this medication suppresses the production of testosterone.
It inhibits the enzymatic activity of steroid 17alpha-monooxygenase, a member of the cytochrome p450 family that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis and it helps in decreasing the levels of other androgens.
The molecular formula of Abiraterone acetate is C26H33NO2 and the weight of the molecule is 391.5 g/mol.
The medication is available in the strength of 250mg and it contains Abiraterone acetate as an active ingredient. It comes in the form of a film-coated tablet and is prescribed by your healthcare professional.
“Arechar Healthcare is committed to proving unmatchable competency and higher excellence in the field of healthcare, specifically in the oncology sector,” said Mr. Harpreet Singh, Founder of Arechar Healthcare. “With the launch of Abiracine, we have taken a step ahead to serve the best and the most affordable medicines to the patients, with utmost accessibility.”
“Our mission is not limited to manufacturing medicines, rather it focuses on the health of patients globally,” he added.
“With every little step towards achieving easy healthcare, we crave to manufacture the best and reliable life-saving drugs, for our mission is to make these medicines accessible to the patients in all the regions of the world,” said Mrs. Ruchika Rajbans, Co-Founder of Arechar Healthcare.
About Arechar Healthcare
Arechar Healthcare is one of the largest leading manufacturers of life-saving drugs, working to serve the patients with the best and approved life-saving drugs at an affordable range of prices. It has attained an authoritative position worldwide in the field of Pharma. It has successfully extended its reach globally and is working with immense insight into humanity. Very few manufacturers possess the drive and determination that the Arechar Healthcare Team has displayed, ever since it started. Focussing on the accessibility and efficacy of life-saving drugs, Arechar Healthcare aims to strengthen the healing and treatment process, with a major focus on oncology care and other diseases that threaten human lives.a
Related hot topics
Bortecine, an effective drug for Blood cancer
Bortecine, for Multiple Myeloma and Mantle Cell Lymphoma
Arechar Healthcare provides independent and precise information about prescription drugs with the related news and press releases. This content is displayed for informational purposes only and is not intended to be an alternative for any medical advice/prescription or treatment. Do not delay or ignore any medical treatment owing to something you’ve read or seen on this website. Also, this website offers links to other websites, enabling the viewers to directly switch to that website for detailed information or accurate references. Thus, Arechar is not responsible for the content displayed on the linked websites or the content of the links in the linked website.